APA (7th ed.) Citation

Orestis Papasouliotis, David Mitchell, Pascal Girard, Fernando Dangond, & Martin Dyroff. (2022). Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study. Wiley.

Chicago Style (17th ed.) Citation

Orestis Papasouliotis, David Mitchell, Pascal Girard, Fernando Dangond, and Martin Dyroff. Determination of a Clinically Effective Evobrutinib Dose: Exposure-response Analyses of a Phase II Relapsing Multiple Sclerosis Study. Wiley, 2022.

MLA (9th ed.) Citation

Orestis Papasouliotis, et al. Determination of a Clinically Effective Evobrutinib Dose: Exposure-response Analyses of a Phase II Relapsing Multiple Sclerosis Study. Wiley, 2022.